At MediBalans, Organix is never read as a standalone report. It is one of the diagnostic layers that reveals how mitochondria are actually functioning — and whether cellular energy production is constrained by toxic burden, methylation failure or substrate deficiency.
Organic acids in urine are metabolic end-products that reveal bottlenecks in the citric acid cycle, carnitine transport and detoxification capacity. These findings determine which intervention to prioritise — before supplements, dietary or hormonal protocols begin.
FIGLU excretion in Organix confirms folate deficiency in the methylation pathway. Elevated methylmalonic acid indicates functional B12 deficiency inside cells — invisible in serum B12. These markers determine whether methylation failure is the primary constraint in the patient.